Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Onc-783 Cancer	OncoC4, Inc.	P1	NR (0)
qls1209 Cancer	Qilu Pharmaceutical Co., Ltd.	P1	NR (0)
yk0901 cells Cancer	Peking University	P1	NR (0)
cvl218 Cancer	Fujian Cancer Hospital	P1/2	NR (0)
Edc-Kras Vaccine Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A	NR (0)
hs-20105 Cancer	Hansoh BioMedical R&D Company	P1/2	NR (0)
Icp-B208 Cancer	Beijing InnoCare Pharma Tech Co., Ltd.	P1/2	NR (0)
Mrna-Lnp Cancer	IntraAb, Inc.	P1/2	NR (0)
zl-85fa tablets Cancer	Chengdu Zenitar Biomedical Technology Co., Ltd	P1/2	NR (0)

Showing 526 to 534 of 534 assets

PreviousPage 22 of 22Next